scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1090745769 |
P356 | DOI | 10.1038/TPJ.2017.10 |
P932 | PMC publication ID | 5773415 |
P698 | PubMed publication ID | 28719597 |
P50 | author | Susan R Heckbert | Q88077554 |
Kent D Taylor | Q89467237 | ||
Heather M. Highland | Q90743082 | ||
Colleen Sitlani | Q102385114 | ||
Vilmundur Gudnason | Q28050060 | ||
Cornelia M. van Duijn | Q28321102 | ||
Stella Trompet | Q28516585 | ||
Albert Hofman | Q30121906 | ||
Albert V. Smith | Q30348342 | ||
Ramachandran S. Vasan | Q30348351 | ||
Bruce M. Psaty | Q30429993 | ||
L. Adrienne Cupples | Q37638868 | ||
Ruifang Li-Gao | Q47502326 | ||
Tamar Sofer | Q55426349 | ||
Kirk Wilhelmsen | Q56863055 | ||
Jerome I Rotter | Q59813011 | ||
Tamara B. Harris | Q63213673 | ||
J Wouter Jukema | Q64858750 | ||
Lenore J Launer | Q66739234 | ||
P2093 | author name string | J Li | |
Y Li | |||
Y Liu | |||
X Li | |||
A G Uitterlinden | |||
J G Wilson | |||
F Sun | |||
B H Stricker | |||
C C Laurie | |||
F R Rosendaal | |||
I Ford | |||
V Salomaa | |||
C J O'Donnell | |||
A P Reiner | |||
D S Evans | |||
K L Wiggins | |||
K M Rice | |||
L A Lange | |||
H J Lin | |||
T Stürmer | |||
J Roach | |||
S R Cummings | |||
K E North | |||
P W Macfarlane | |||
R de Mutsert | |||
J S Floyd | |||
J C Bis | |||
C R Lee | |||
J A Brody | |||
N Sotoodehnia | |||
B M Buckley | |||
J D Stewart | |||
Q Duan | |||
E Z Soliman | |||
R Noordam | |||
M A Laaksonen | |||
A Isaacs | |||
D O Mook-Kanamori | |||
C L Avery | |||
L Broer | |||
R C Kaplan | |||
C Newton-Cheh | |||
K Porthan | |||
J A Kors | |||
E A Whitsel | |||
G M Peloso | |||
A A Seyerle | |||
E L Busch | |||
M D Napier | |||
R Méndez-Giráldez | |||
K Kristiansson | |||
A M Stilp | |||
K F Kerr | |||
S M Gogarten | |||
Y-DI Chen | |||
P2860 | cites work | Nuclear membrane R-type calcium channels mediate cytosolic ET-1-induced increase of nuclear calcium in human vascular smooth muscle cells | Q86871711 |
[Customizing dosage drugs what contribution in therapeutic drug monitoring?] | Q87223601 | ||
Using pharmacogenetics in real time to guide therapy: the warfarin example | Q87440996 | ||
An integrated map of genetic variation from 1,092 human genomes | Q22122153 | ||
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 | ||
ConsensusPathDB: toward a more complete picture of cell biology | Q24611619 | ||
A map of human genome variation from population-scale sequencing | Q24617794 | ||
The human genome browser at UCSC | Q24672361 | ||
A haplotype map of the human genome | Q24679827 | ||
The International HapMap Project | Q27860695 | ||
Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype | Q28304358 | ||
Stanniocalcin 2 is a negative modulator of store-operated calcium entry | Q28568485 | ||
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization | Q28654771 | ||
Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's Disease dataset | Q28743536 | ||
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts | Q28751965 | ||
METAL: fast and efficient meta-analysis of genomewide association scans | Q29547217 | ||
Integrating common and rare genetic variation in diverse human populations | Q29547220 | ||
KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
Generalized estimating equations for genome-wide association studies using longitudinal phenotype data. | Q30858387 | ||
MAGMA: generalized gene-set analysis of GWAS data | Q30935493 | ||
Drug-induced prolongation of the QT interval | Q33151147 | ||
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians | Q33163257 | ||
Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study | Q33317464 | ||
PANTHER pathway: an ontology-based pathway database coupled with data analysis tools | Q33481679 | ||
Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes | Q33580059 | ||
Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008 | Q33696671 | ||
Clinical pharmacogenetics implementation: approaches, successes, and challenges | Q33825186 | ||
Gene--environment-wide association studies: emerging approaches | Q33937986 | ||
A partition-based approach to identify gene-environment interactions in genome wide association studies. | Q34085788 | ||
Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review | Q34102026 | ||
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans | Q34327265 | ||
Gene-environment interactions in human diseases | Q34407923 | ||
Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods | Q34601554 | ||
Selection bias in rheumatic disease research | Q34662693 | ||
Modulators of normal electrocardiographic intervals identified in a large electronic medical record | Q34674230 | ||
Pathway analysis of genome-wide data improves warfarin dose prediction | Q34790566 | ||
Pharmacogenomic testing and the prospect of individualized treatment | Q35062345 | ||
What Clinicians Should Know About the QT Interval | Q35112554 | ||
A multi-trait, meta-analysis for detecting pleiotropic polymorphisms for stature, fatness and reproduction in beef cattle. | Q35133219 | ||
Disrupted-in-schizophrenia-1 (DISC1) Regulates Endoplasmic Reticulum Calcium Dynamics. | Q35138731 | ||
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways | Q35230796 | ||
GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation | Q35418401 | ||
Biological interpretation of genome-wide association studies using predicted gene functions | Q35571093 | ||
The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients | Q35612903 | ||
QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey | Q35921045 | ||
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression | Q35987735 | ||
A review of uses of health care utilization databases for epidemiologic research on therapeutics | Q36111277 | ||
Heritabilities, proportions of heritabilities explained by GWAS findings, and implications of cross-phenotype effects on PR interval | Q36236086 | ||
Genetics and variable drug response | Q36515108 | ||
Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects | Q36782845 | ||
Electronic medical records for genetic research: results of the eMERGE consortium | Q36948611 | ||
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics | Q37130316 | ||
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study | Q37138272 | ||
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval | Q37154348 | ||
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide | Q37192199 | ||
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic | Q37217719 | ||
Variability in response to cardiovascular drugs | Q37230209 | ||
Clinical correlates and heritability of QT interval duration in blacks: the Jackson Heart Study. | Q37409548 | ||
Causal analysis approaches in Ingenuity Pathway Analysis | Q37592031 | ||
Genetic epidemiology with a capital E, ten years after | Q37962479 | ||
Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics | Q38180204 | ||
Sources of interindividual variability | Q38187621 | ||
The emerging era of pharmacogenomics: current successes, future potential, and challenges | Q38200683 | ||
Trafficking mechanisms and regulation of TRPC channels | Q38228210 | ||
ConsensusPathDB--a database for integrating human functional interaction networks | Q38386413 | ||
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. | Q39920642 | ||
An Adaptive Association Test for Multiple Phenotypes with GWAS Summary Statistics | Q40401102 | ||
Transethnic meta-analysis of genomewide association studies | Q42572583 | ||
Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search | Q43578834 | ||
Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study | Q44039631 | ||
Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. | Q44327990 | ||
Diuretic therapy for hypertension and the risk of primary cardiac arrest | Q45285350 | ||
Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008. | Q50116943 | ||
Functional characterization of 32 CYP2C9 allelic variants. | Q50920357 | ||
Pharmacogenomics update in pancreatic cancer. | Q51294672 | ||
The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. | Q51564142 | ||
Selection bias in the assessment of gene-environment interaction in case-control studies. | Q52953340 | ||
An approximate distribution of estimates of variance components. | Q53055035 | ||
International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice. | Q53265213 | ||
Pharmacogenomics, ancestry and clinical decision making for global populations | Q57278395 | ||
Genetic factors in the electrocardiogram and heart rate of twins reared apart and together | Q69950887 | ||
Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group | Q72423837 | ||
QT interval in twins | Q73949702 | ||
Interaction of ACE and CYP11B2 genes on blood pressure response to hydrochlorothiazide in Han Chinese hypertensive patients | Q83302867 | ||
[Effect of CYP11B2 gene -344T/C polymorphism on renin-angiotensin-aldosterone system activity and blood pressure response to hydrochlorothiazide] | Q83397029 | ||
P433 | issue | 2 | |
P921 | main subject | pharmacogenomics | Q1152227 |
ageing research | Q110477187 | ||
multiethnicity | Q111242702 | ||
P304 | page(s) | 215-226 | |
P577 | publication date | 2017-07-18 | |
P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
P1476 | title | Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology | |
P478 | volume | 18 |
Search more.